NAFLD: comorbidity and associated diseases-Reference-Cited by-同舟云学术

NAFLD: comorbidity and associated diseases

Published:2020-03-02 Issue:10 Volume:1 Page:57-65
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:jour

Author:

Livzan M. A.¹,Gaus O. V.¹,Nikolaev N. A.¹,Krolevetz T. S.¹

Affiliation:

1. Federal State Educational Establishment of Higher Education Omsk State Medical University of the Ministry of Health of the Russian Federation

Abstract

Non-alcoholic fatty liver disease (NAFLD) went beyond the competence of a gastroenterologist and acquired the character of a multidisciplinary problem. NAFLD requires the attention of many professionals. A characteristic feature of NAFLD is the variety of concomitant diseases and pathological conditions with common pathophysiological mechanisms. This review summarizes and presents the data available in the modern literature on the association of NAFLD with cardiovascular diseases, type 2 diabetes mellitus, hypothyroidism, polycystic ovary syndrome, chronic kidney disease, colorectal cancer, obstructive sleep apnea, osteoporosis, psoriasis.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference54 articles.

1. Драпкина О.М., Буеверов А. О. Неалкогольная жировая болезнь печени как мультидисциплинарная патология. М.: Видокс, 2017, 104 с. Drapkina O. M., Bueverov A. O. Nealkogol’naya zhirovaya bolezn’ pecheni kak mul’tidistciplinarnaya patologiya [Non-alcoholic fatty liver disease as a multidisciplinary pathology]. M.: Vidoks, 2017, 104 p.

2. Younossi Z.M., Koenig A. B., Abdelatif D. et al. Global epidemiology of nonalcoholic fatty liver disease – Metaanalytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016, vol. 64, no. 1, pp. 73–84.

3. Диагностика и лечение неалкогольной жировой болезни печени: методические рекомендации для врачей Российского общества по изучению печени. М.: МЕДпресс-информ, 2015, 48 c. Diagnostika i leceniye nealkogol’noi zhirovoi bolezni pecheni: metodicheskiye recommendatcii dlya vrachey Rossiiskogo obshestva po izucheniyu pecheni [Diagnosis and treatment of non-alcoholic fatty liver disease: guidelines for doctors of the Russian society for the study of the liver]. M.: MEDpress-inform, 2015, 48 p.

4. Anstee Q.M., Targher G., Day C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol, 2013, no. 10, pp. 330–344.

5. Miele L., Targher G. Understanding the association between developing a fatty liver and subsequent cardio- metabolic complications. Expert Rev Gastroenterol Hepatol, 2015, no. 9, pp. 1243–1245.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolution of the Expert Forum "New therapeutic horizons of NAFLD";Terapevticheskii arkhiv;2024-03-30

2. Role of adipokines in the formation of metabolic disorders in conditions of metabolic-associated fatty liver disease (MAFLD);Experimental and Clinical Gastroenterology;2024-03-15

3. Non-alcoholic fatty liver disease and psoriasis: mechanisms of comorbidity and approaches to therapy;Meditsinskiy sovet = Medical Council;2024-03-08

4. DIAGNOSTIC VALUE OF NITROGEN METABOLISM DISORDERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN COMORBID PATIENTS WITH METABOLIC SYNDROME AND STRATIFICATION OF DISEASE STAGES;Ulyanovsk Medico-biological Journal;2023-09-29

5. Liver fibrosis in a comorbid patient with metabolicassociated (non-alcoholic) fatty liver disease (MAFLD-NAFLD) and cardiovascular disease;Experimental and Clinical Gastroenterology;2023-07-26